Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919347 · ClinicalTrials.gov registry record
The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 100
- Enrollment target
NCT00919347 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants.
The verdict
NCT00919347 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system (ANS) dysfunction, and autonomic dysfunction as well as the overall sympathovagal balance (SB) in the CEFH population of diabetic patients versus non-diabetic patients undergoing elective vitreoretinal surgery.
Interventions
- OTHER ANSAR ANX 3.0 Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00919347
The ClinicalTrials.gov registry entry for NCT00919347 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ANSAR ANX 3.0 Software is the first listed.
NCT00919347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00919347 about?
NCT00919347 is a clinical study titled "The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction". The purpose of this study is to measure the prevalence and severity of cardiac autonomic neuropathy (CAN), diabetic autonomic neuropathy (DAN) which in non-diabetics is termed advanced nervous system (ANS) dysfunction, and autonomic dysfunction as well as the overall sympathovagal balance (SB) in th...
What is the current status of trial NCT00919347?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-06. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00919347?
The interventions under investigation include: ANSAR ANX 3.0 Software (OTHER).
Who is sponsoring clinical trial NCT00919347?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.